Publications
2025
Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction.
Wood, G. K., Sargent, B. F., Ahmad, Z. -U. -A., Tharmaratnam, K., Dunai, C., Egbe, F. N., . . . Leek, E. C. (2024). Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction.. Nature medicine. doi:10.1038/s41591-024-03309-8
2024
Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain
Dunai, C., Hetherington, C., Boardman, S. A., Clark, J. J., Sharma, P., Subramaniam, K., . . . Michael, B. D. (2024). Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain. Frontiers in Immunology, 15. doi:10.3389/fimmu.2024.1440324
Diagnostic markers of acute encephalitis syndrome and COVID-associated multisystem inflammatory syndrome in children from Southern India.
Damodar, T., Dunai, C., Prabhu, N., Jose, M., Akhila, L., Kinhal, U. V., . . . Mani, R. S. (2024). Diagnostic markers of acute encephalitis syndrome and COVID-associated multisystem inflammatory syndrome in children from Southern India.. Journal of medical virology, 96(5), e29666. doi:10.1002/jmv.29666
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.
Razmara, A. M., Farley, L. E., Harris, R. M., Judge, S. J., Lammers, M., Iranpur, K. R., . . . Canter, R. J. (2024). Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.. Journal for immunotherapy of cancer, 12(4), e007963. doi:10.1136/jitc-2023-007963
A rare case of opsoclonus myoclonus syndrome following COVID-19 illness.
Shil, R., Dunai, C., Seed, A., Wood, G., Collie, C., Pendered, S., . . . Michael, B. (2024). A rare case of opsoclonus myoclonus syndrome following COVID-19 illness.. Clinical medicine (London, England), 23 Suppl 6, 40. doi:10.7861/clinmed.23-6-s40
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael, B. D., Dunai, C., Needham, E. J., Tharmaratnam, K., Williams, R., Huang, Y., . . . Menon, D. K. (2024). Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.. Nature communications, 15(1), 2918. doi:10.1038/s41467-024-47320-6
Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling.
Dunai, C., Iyer, S. S., & Murphy, W. J. (2024). Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling.. Frontiers in immunology, 15, 1548624. doi:10.3389/fimmu.2024.1548624